Patents by Inventor Laurent Villard

Laurent Villard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of MeCP-2 Associated Disorders
    Publication number: 20150265554
    Abstract: The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Inventors: Jean-Christophe Roux, Laurent Villard, Frédérie Saudou
  • TREATMENT OF MECP-2 ASSOCIATED DISORDERS
    Publication number: 20130316961
    Abstract: The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome.
    Type: Application
    Filed: October 24, 2011
    Publication date: November 28, 2013
    Applicants: UNIVERSITÉ D'AIX-MARSEILLE, INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (Institut National de la Santé et de la Recherche Médicale)
    Inventors: Jean-Christophe Roux, Laurent Villard, Frédéric Saudou